Name:           Emilija Veljkovic, PhD
Date of birth: 27th April 1972.
Nationality:   Swiss and Serbian
e-mail:            emilija.veljkovic@pmi.com

Manager Scientific and Medical affairs
Molecular biologist with 8 years of experience in the generation of in vivo scientific evidences related to the tobacco harm reduction at Philip Morris International
Leadership of preparation of scientific reports, book chapters, a book, publications and presentations of the scientific data internally and externally
Strong experience in the standard and systems toxicology product assessment
Key leader of the development and presenter of the scientific part of the novel business concept to the PMI Senior Management Team – Better Life
Managed (remotely and on site) a group of 5 scientists in a multicultural environment (Singapore) responsible for the conduct of in vivo studies
Defined short- and long-term scientific strategies to study disease mechanisms of smoking related diseases in a cross-functional manner
Data interpretation, integrity and robustness
Project leader of 10 complex in vivo studies designed to characterize the impact of novel tobacco/nicotine containing products in initiation and development of smoke related pathologies such as lung cancer, COPD and CVD

Personal skills

Independent, reliable, results oriented, self-motivated
Excellent written and oral communication skills in English
Ability to motivate others
Open and respectful communication in a multicultural environment



November 2012 Certificate of Advanced Studies, Management of Medtech, Biotech and Pharma ventures, Ecole polytechnique fédérale de Lausanne
September 2004-October 2007 Postdoc at the Institute for Molecular Cancer Research at the University of Zurich
May 2000-July 2004 PhD at the Institute of Physiology University of Zurich
Project: Determination of physiological and biochemical properties of novel amino acid transporter proteins from round worm Caenorhabditis elegans, Ag research, Upper Hutt New Zealand

1995-1999 Master thesis project at the Institute for Nuclear Sciences Vinca Belgrade – raised own funding in economically and socially challenging circumstances for the basic research
Project: mutational status of RET oncogene in medullary thyroid carcinomas, Oncology Clinic Belgrade, Serbia

1990-1995 Student at the University of Belgrade